Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia
Editorial Group: Cochrane Schizophrenia Group
Published Online: 8 JUL 2014
Assessed as up-to-date: 17 NOV 2010
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Tardy M, Dold M, Engel RR, Leucht S. Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia. Cochrane Database of Systematic Reviews 2014, Issue 7. Art. No.: CD009396. DOI: 10.1002/14651858.CD009396.pub2.
- Publication Status: New
- Published Online: 8 JUL 2014
Current VersionTrifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia
Magdolna Tardy, Markus Dold, Rolf R Engel and Stefan Leucht
Article first published online: 8 JUL 2014 | DOI: 10.1002/14651858.CD009396.pub2
Previous versions of this article and their online publication dates
Version 1Trifluoperazine versus low-potency first generation antipsychotic drugs for schizophrenia
Magdolna Tardy, Stefan Leucht, Andrey Potapov, Rolf Engel, Markus Dold and Werner Kissling
Article first published online: 5 OCT 2011 | DOI: 10.1002/14651858.CD009396